Viking Therapeutics Company Insiders

Viking Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.1268) % which means that it has lost $0.1268 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.155) %, meaning that it created substantial loss on money invested by shareholders. Viking Therapeutics' management efficiency ratios could be used to measure how well Viking Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.22 in 2025. Return On Capital Employed is likely to drop to -0.27 in 2025. At this time, Viking Therapeutics' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 443.4 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 755.8 K in 2025. Common Stock Shares Outstanding is likely to rise to about 113.9 M in 2025, despite the fact that Net Loss is likely to grow to (58.9 M).

Viking Therapeutics Workforce Comparison

Viking Therapeutics Insider Trading History

Viking Therapeutics Notable Stakeholders

The success or failure of an entity such as Viking Therapeutics often depends on how effective the management is. Viking Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Viking management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Viking management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Viking Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Viking Therapeutics. Check Viking Therapeutics' Beneish M Score to see the likelihood of Viking Therapeutics' management manipulating its earnings.

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.